US › Healthcare

OPTIMIZERx Corp (OPRX)

US · Healthcare · Health Information Services

$6.85+4.58%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$19.8M
Revenue YoY
-9.5%
Net profit
$-495,000
Profit YoY
+77.5%
EPS
$0.00
EPS estimate
$0.03
Net margin
-2.5%

EPS came in at 0.00 against a street estimate of 0.03 — a miss of 100.0%.

Key statistics

Market cap
$113.5M
P/E
16.8
Forward P/E
6.6
P/B
0.87
Book value
$6.91
EPS (TTM)
$0.36
52-week high
$22.25
52-week low
$4.54
50-day MA
$5.66
200-day MA
$9.72
Beta
1.08

Analyst view

Analysts rate OPTIMIZERx Corp a buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $12.40.

Shareholding

Insiders
12.88%
Institutions
80.82%

Largest institutional holders

FundStake
Whetstone Capital Advisors, LLC8.04%
BlackRock Inc6.20%
Royce & Associates, LP4.73%
Parkman Healthcare Partners LLC3.89%
Vanguard Capital Management, LLC3.65%
Kennedy Capital Management Inc3.50%
Blair William & Co3.28%
Rice Hall James & Associates, LLC3.21%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for OPTIMIZERx Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.